3-amino-4-(5-(trifluoromethyl)furan-2-yl)-5,6,7,8,9,10-hexahydrocycloocta[b]thieno[3,2-e]pyridine-2-carboxamide

ID: ALA1089019

PubChem CID: 46884209

Max Phase: Preclinical

Molecular Formula: C19H18F3N3O2S

Molecular Weight: 409.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)c1sc2nc3c(c(-c4ccc(C(F)(F)F)o4)c2c1N)CCCCCC3

Standard InChI:  InChI=1S/C19H18F3N3O2S/c20-19(21,22)12-8-7-11(27-12)13-9-5-3-1-2-4-6-10(9)25-18-14(13)15(23)16(28-18)17(24)26/h7-8H,1-6,23H2,(H2,24,26)

Standard InChI Key:  VHLDQURHHUWKSX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    5.8910  -23.0742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8911  -22.2467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4758  -21.6619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4759  -23.6548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3033  -23.6548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3033  -21.6618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8839  -22.2467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8808  -23.0732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5938  -23.4873    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5960  -21.8361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3096  -22.2465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3071  -23.0783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0974  -23.3378    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   10.5885  -22.6663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1016  -21.9919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3589  -21.2081    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.4135  -22.6688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8238  -23.3846    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.8282  -21.9556    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5955  -21.0111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2575  -20.5259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0021  -19.7414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1770  -19.7418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9227  -20.5266    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6916  -19.0747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0267  -18.3208    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.8712  -19.1615    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.9708  -18.6583    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
  1  2  1  0
 15 16  1  0
  7  8  2  0
 14 17  1  0
  2  3  1  0
 17 18  2  0
  8  9  1  0
 17 19  1  0
  9 12  2  0
 10 20  1  0
 20 21  2  0
  1  4  1  0
 11 10  2  0
 10  7  1  0
 11 12  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 20  1  0
  4  5  1  0
 23 25  1  0
  5  8  1  0
 25 26  1  0
  7  6  1  0
 25 27  1  0
  6  3  1  0
 25 28  1  0
M  END

Associated Targets(Human)

EEF2K Tchem Serine/threonine-protein kinase EEF2K (1246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 409.43Molecular Weight (Monoisotopic): 409.1072AlogP: 4.92#Rotatable Bonds: 2
Polar Surface Area: 95.14Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.52CX LogD: 4.52
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.63Np Likeness Score: -1.30

References

1. Lockman JW, Reeder MD, Suzuki K, Ostanin K, Hoff R, Bhoite L, Austin H, Baichwal V, Adam Willardsen J..  (2010)  Inhibition of eEF2-K by thieno[2,3-b]pyridine analogues.,  20  (7): [PMID:20189382] [10.1016/j.bmcl.2010.02.005]

Source